- Home
- PESI vs FENC Comparison
PESI vs FENC Comparison
Compare PESI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- FENC
- Stock Information
- Founded
- PESI 1990
- FENC 1996
- Country
- PESI United States
- FENC United States
- Employees
- PESI N/A
- FENC N/A
- Industry
- PESI Environmental Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PESI Industrials
- FENC Health Care
- Exchange
- PESI Nasdaq
- FENC Nasdaq
- Market Cap
- PESI 153.1M
- FENC 156.9M
- IPO Year
- PESI 1992
- FENC 2001
- Fundamental
- Price
- PESI $9.39
- FENC $5.95
- Analyst Decision
- PESI Strong Buy
- FENC Strong Buy
- Analyst Count
- PESI 1
- FENC 2
- Target Price
- PESI $18.00
- FENC $14.00
- AVG Volume (30 Days)
- PESI 184.8K
- FENC 50.4K
- Earning Date
- PESI 05-08-2025
- FENC 05-20-2025
- Dividend Yield
- PESI N/A
- FENC N/A
- EPS Growth
- PESI N/A
- FENC N/A
- EPS
- PESI N/A
- FENC N/A
- Revenue
- PESI $59,419,000.00
- FENC $47,538,000.00
- Revenue This Year
- PESI $38.20
- FENC $2.68
- Revenue Next Year
- PESI $98.88
- FENC $71.63
- P/E Ratio
- PESI N/A
- FENC N/A
- Revenue Growth
- PESI N/A
- FENC 123.69
- 52 Week Low
- PESI $6.25
- FENC $3.96
- 52 Week High
- PESI $16.25
- FENC $10.07
- Technical
- Relative Strength Index (RSI)
- PESI 68.56
- FENC 51.33
- Support Level
- PESI $8.28
- FENC $5.85
- Resistance Level
- PESI $9.76
- FENC $6.61
- Average True Range (ATR)
- PESI 0.59
- FENC 0.36
- MACD
- PESI 0.12
- FENC 0.06
- Stochastic Oscillator
- PESI 79.67
- FENC 54.20
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.